Skip to main content
OpenTrials
Completed

NCT Number: NCT02107677

Specificity Study of Diagnostic for Early Detection of Dengue Infection

This study assesses the specificity of DENV Detect™ NS1 ELISA versus standard reference tests (e.g. PCR or viral culture) for dengue diagnosis in the US.

DENV Detect™ NS1 ELISA serves as an aid in the clinical laboratory diagnosis of early stages of Dengue infection in patients with clinical symptoms consistent with Dengue infection. This test is intended to be used on sera obtained within the first 7 days of symptoms. DENV Detect™ NS1 ELISA and rapid test results (positive or negative) must be confirmed by testing with a reference standard test.

This study will use archived, leftover human serum samples that have been sequentially collected from areas non-endemic for Dengue infection. Each specimen must have been collected within the first 7 days of symptoms, and must be accompanied by clinical data demonstrating that the individual had symptoms consistent with Dengue infection. The samples will have no personally identifiable information.

ELISAs and reference tests will be performed by different operators who are laboratory staff members. These staff members, blinded to each other's results, will evaluate the samples from each method independently.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infectious Diseases Communicable Diseases Disease Attributes Infections Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

State of Florida Dept. of Health Bureau of Laboratories Virology

Jacksonville, Florida, 32208, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All age groups and both sexes.
  • Serum samples collected within 1- 7 days of onset of symptoms consistent with Dengue virus infection.
  • Information must be available about symptoms, age, and sex of patients from which samples are collected.

Exclusion criteria

  • Any sample(s) with linked personal identifiers or any sample for which personal information can be discovered will be excluded.

Treatment and study plan

Primary outcomes

  1. number of subjects with negative result

    Time frame: one day

Sponsors and collaborators

Lead sponsor

InBios International, Inc.

Industry

Registry information

Official study title

Determination of Estimated Specificity of DENV Detect NS1 ELISAs

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Apr 8, 2014
Registry last updated
Aug 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.